The FDA has increasingly accepted less data and shortened its review times for drugs, according to a new study in JAMA.

from MarketWatch.com - Top Stories https://ift.tt/2TpRw8D
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2TpRw8D
via IFTTT
Kommentare
Kommentar veröffentlichen